ATLANTA — Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving treatments to market, drug companies say. Traditionally, developing ...

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...

A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the filing of a divisional patent application for its Trap & Target (T&T) platform technology with the Israel Patent Office.